BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

MAHAVIRADVANCEDREMEDIES01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

MAHAVIRADVANCEDREMEDIES01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
21-Nov-2023	BC	Trading Members of the Exchange are hereby informed that the undermentioned 73 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with	23-Nov-2023
13-Jan-2015	BC	Quarterly Results	12-Feb-2015
16-Jan-2015	BC	Mahavir Advanced Remedies Ltd has informed BSE that Mr. Sanjay Kr. Choradia has been appointed as additional Director (Independent) w.e.f. January 15, 2015 subject to approval of Members in forthcomi	15-Jan-2015
01-Jan-2015	BC	All Trading Members of the Exchange Sub: Suspension in trading of securities Trading members are hereby informed that pursuant to directions received from SEBI, as a surveillance measur	07-Jan-2015
01-Jan-2015	BC	All Trading Members of the Exchange Sub: Suspension in trading of securities Trading members are hereby informed that pursuant to directions received from SEBI, as a surveillance measur	07-Jan-2015

No Rights has been declared by MAHAVIRADVANCEDREMEDIES

Book Closure

Record Date	Split Date	Purpose
23-Nov-2023	-	Trading Members of the Exchange are hereby informed that the undermentioned 73 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with
12-Feb-2015	-	Quarterly Results
15-Jan-2015	-	Mahavir Advanced Remedies Ltd has informed BSE that Mr. Sanjay Kr. Choradia has been appointed as additional Director (Independent) w.e.f. January 15, 2015 subject to approval of Members in forthcomi
07-Jan-2015	-	All Trading Members of the Exchange Sub: Suspension in trading of securities Trading members are hereby informed that pursuant to directions received from SEBI, as a surveillance measur
07-Jan-2015	-	All Trading Members of the Exchange Sub: Suspension in trading of securities Trading members are hereby informed that pursuant to directions received from SEBI, as a surveillance measur

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Lupin Ltd ₹1,647.65(+1.75/0.11%)	1,647.65	+1.75	75,091.67	132.46	36.44	3.90
Ipca Laboratories Ltd ₹1,351.00(+11.50/0.86%)	1,351.00	+11.50	34,275.44	90.72	62.23	5.52
J B Chemicals & Pharmaceuticals Ltd ₹1,885.60(-19.65/-1.03%)	1,885.60	-19.65	29,263.53	81.31	57.83	10.91
Sanofi India Ltd ₹8,677.75(+352.20/4.23%)	8,677.75	+352.20	19,984.86	59.90	33.85	19.68
IOL Chemicals & Pharmaceuticals Ltd ₹392.30(-1.40/-0.36%)	392.30	-1.40	2,303.02	-4.21	13.36	1.45

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 14	Sep 14	Jun 14	Mar 14	Dec 13	Sep 13
Gross Sales	0.03	0.13	0.02	0.02	0.03	0.03
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.03	0.13	0.02	0.02	0.03	0.03
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.00	0.00	0.00	0.26	0.00	0.00
Total Income	0.03	0.13	0.02	0.28	0.03	0.03
Total Expenditure	0.02	0.02	0.02	0.15	0.01	0.05
PBIDT	0.01	0.11	0.01	0.13	0.02	-0.02
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.01	0.11	0.01	0.13	0.02	-0.02
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.01	0.11	0.01	0.13	0.02	-0.02
Extra-ordinary Items	0.00	0.00	0.00	0.04	0.00	-0.04
Adjusted Profit After Extra-ordinary item	0.01	0.11	0.01	0.09	0.02	0.02

EPS (Unit Curr.)	0.01	0.10	0.01	0.11	0.02	-0.02
EPS (Adj) (Unit Curr.)	0.01	0.10	0.01	0.11	0.02	-0.02
Calculated EPS (Unit Curr.)	0.01	0.10	0.01	0.11	0.02	0.00
Calculated EPS (Adj) (Unit Curr.)	0.01	0.10	0.01	0.11	0.02	0.00
Calculated EPS (Ann.) (Unit Curr.)	0.05	0.38	0.03	0.46	0.06	0.00
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.05	0.38	0.03	0.46	0.06	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	11.36	11.36	11.36	11.36	11.36	11.36
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	11249550.00	11249550.00	11249550.00	11249550.00	10438800.00	10438800.00
Public Shareholding (% in Equity)	99.03	99.03	99.03	99.03	91.90	91.90

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	109650.00	109650.00	109650.00	109650.00	920400.00	920400.00
Non Encumbered - % in Total Promoters Holding	100.00	100.00	100.00	100.00	100.00	100.00
Non Encumbered - % in Total Equity	0.97	0.97	0.97	0.97	8.10	8.10

PBIDTM(%)	33.33	84.62	50.00	650.00	66.67	-66.67
PBDTM(%)	33.33	84.62	50.00	650.00	66.67	-66.67
PATM(%)	33.33	84.62	50.00	650.00	66.67	-66.67

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010
Cash and Cash Equivalents at Beginning of the year	0.01	0.03	0.01	0.02	0.02
Net Cash from Operating Activities	0.48	-8.17	0.01	-0.01	0.00
Net Cash Used In Investing Activities	0.00	0.00	0.01	0.00	0.00
Net Cash Used In Financing Activities	0.00	8.15	0.00	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	0.48	-0.02	0.02	-0.01	0.00
Cash And Cash Equivalents At End Of The Year	0.49	0.01	0.03	0.01	0.02

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.97%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

99.03%

**Promoter pledged shareholding 0.97%

About Mahavir Advanced Remedies Ltd

Mahavir Advanced Remedies Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 171.14 crores. It has reported a sales of Rs. 0.03 crores and a net profit of Rs. 0.01 crores for the quarter ended December 2018. The company management includes BVS Kotewara Rao, Mani Murugadoss Rao,Shantilal Purohit,Anitha Mahesh,BVS Kotewara Rao,Sanjay Kr Choradia (Mahavir Advanced Remedies Ltd) among others.

Chairman

BVS Kotewara Rao

Registered office

Office No 67/2 III Street,Second Floor N M Road,Chennai,Tamil Nadu,600029

FAX :

Background

Incorporation Year1992

Face Value₹10

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0